USITC Commissioner Series: What Divides the International Trade Commission?
May 1, 2024, 8:12 AM
By: Brian P. Johnson
At the International Trade Commission, a panel of up to six Commissioners is the gatekeeper of Section 337. Before the termination of any investigation, an administrative law judge's initial determination is always subject to Commission review. However, the Commissioners do not always agree and have recently shown increasing disparity on issues focused on the nuance of Section 337, like the domestic industry requirement and forms of remedy. To help navigate these disagreements, below is a comprehensive and searchable resource for all Commissioner dissents and concurrences over the last ten years. (Last updated through December 2023)
Search by Investigation Number: e.g., 1344, 794, 1190
Search by Issue: e.g., Remedy, CDO, Domestic Industry, Infringement
Search by Commissioner: e.g., Stayin, Johanson, Kearns
Our coverage in the USITC Commissioner Series details some of the key conclusions that can be drawn from this data. Read part one here, part two here, part three here and part five here.
To help visualize, below is an interactive identification of all dissents and concurrences. The data can be grouped or shaded by issue or commissioner. They can also be resized by the length of the opinion.

To subscribe to our publications, click here.
Tags
News & Insights
News & Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
